Table 2.
Variable | Mortality status | Odds ratio (CI) | p-value | |
---|---|---|---|---|
Alive N = 68,848 |
Died in hospital N = 48,356 |
|||
Demographic | ||||
Age in years, mean (SD) | 58.42 (18.17) | 66.29 (17.48) | 1.03 (1.02-1.03) | < 0.001 |
Age group, years, % | ||||
18-29 | 9.01 | 4.68 | ref | ref |
30-39 | 7.89 | 4.44 | 1.08 (0.99-1.18) | 0.03 |
40-49 | 13.10 | 8.21 | 1.21 (1.11-1.31) | < 0.001 |
50-59 | 18.10 | 13.54 | 1.44 (1.34-1.55) | < 0.001 |
60-69 | 19.84 | 18.03 | 1.75 (1.63-1.88) | < 0.001 |
70-79 | 20.20 | 25.51 | 2.43 (2.26-2.61) | < 0.001 |
≥80 | 11.87 | 26.50 | 4.15 (3.86-4.47) | < 0.001 |
Female, % | 41.40 | 44.85 | 1.15 (1.12-1.19) | < 0.001 |
Race, % | ||||
White | 58.48 | 59.36 | ref | ref |
Black | 9.87 | 9.56 | 0.95 (0.90-1.01) | 0.02 |
Hispanic | 7.54 | 7.18 | 0.94 (0.88-1.00) | 0.01 |
Asian or Pacific Islander | 1.51 | 1.90 | 1.25 (1.11-1.40) | < 0.001 |
Native American | 0.55 | 0.45 | 0.81 (0.65-1.01) | < 0.001 |
Other | 2.77 | 2.75 | 0.98 (0.89-1.08) | 0.57 |
Expected Primary Payer, % | ||||
Medicare | 44.48 | 59.79 | ref | ref |
Medicaid | 12.93 | 8.89 | 0.51 (0.49-0.54) | < 0.001 |
Private including HMO | 31.36 | 21.93 | 0.52 (0.50-0.54) | < 0.001 |
Self-pay | 5.31 | 5.45 | 0.76 (0.81-0.82) | < 0.001 |
No charge | 0.73 | 0.47 | 0.48 (0.39-0.59) | < 0.001 |
Other | 4.91 | 3.27 | 0.50 (0.46-0.54) | < 0.001 |
Comorbid Conditionsa | ||||
Elixhauser Comorbidity Score, mean (SD) | 7.63 (7.20) | 8.98 (7.44) | 1.03 (1.02-1.03) | < 0.001 |
Severity Measures, % | ||||
APR-DRG risk of mortalityb | ||||
Minor likelihood of dying | 2.49 | 0.25 | ref | ref |
Moderate likelihood of dying | 10.12 | 1.97 | 1.95 (1.50-2.52) | < 0.001 |
Major likelihood of dying | 33.96 | 18.32 | 5.41 (4.23-6.91) | < 0.001 |
Extreme likelihood of dying | 52.57 | 78.46 | 14.97 (11.73-19.10) | < 0.001 |
APR-DRG severity of illness subclassb | ||||
Minor loss of function | 0.03 | 0.01 | ref | ref |
Moderate loss of function | 0.82 | 0.49 | 1.93 (0.53-6.98) | 0.19 |
Major loss of function | 9.86 | 9.35 | 3.06 (0.86-10.92) | 0.02 |
Extreme loss of function | 88.43 | 89.43 | 3.26 (0.91-11.61) | 0.02 |
Discharge Quarter | ||||
January –March | 25.11 | 26.46 | ref | ref |
April-June | 25.91 | 25.14 | 0.92 (0.88-0.96) | < 0.001 |
July-September | 25.60 | 25.02 | 0.93 (0.89-0.97) | < 0.001 |
October-December | 23.33 | 23.29 | 0.95 (0.91-0.99) | < 0.001 |
Admission-Weekday v. Weekend | ||||
Monday-Friday | 78.00 | 77.95 | ref | ref |
Saturday or Sunday | 22.00 | 22.05 | 1.00 (0.97-1.01) | 0.84 |
Admission Typec | ||||
Emergency | 46.51 | 52.60 | ref | ref |
Urgent | 14.76 | 15.24 | 0.91 (0.87-0.95) | < 0.001 |
Elective | 21.82 | 16.23 | 0.66 (0.63-0.69) | < 0.001 |
Trauma center (beginning in 2003) | 6.12 | 3.79 | 0.55 (0.51-0.59) | < 0.001 |
Other | 0.02 | 0.01 | 0.37 (0.10-1.37) | 0.05 |
Length of Stay, Median (IQR) | 23 (16-35) | 10 (4-19) | 0.94 (0.94-0.95) | < 0.001 |
OR Procedure | 77.16 | 63.61 | 0.52 (0.50-0.54) | < 0.001 |
ARDS = Acute Respiratory Distress Syndrome; APR-DRG = All patient refined diagnosis related grouping; CI = 99% confidence interval; HMO = Health Maintenance Organization; NIS=Nationwide Inpatient Sample; OR = operating room; SD = standard deviation
This represents a weighted Elixhauser Score based on comorbidities on discharge record. Comorbidities within the Healthcare Cost and Utilization Project (HCUP) are determined using the Agency for Healthcare Research and Quality (AHQR) comorbidity software which seeks to identify comorbid medical conditions present prior to admission (https://www.hcup-us.ahrq.gov/tools_software.jsp).
The All Patient Refined Diagnosis Related Grouping (APR-DRG) risk of mortality and severity of illness subclass are assigned using a software developed and maintained by 3M Health Information Systems (www.hcup-us.ahrq.gov). Category of ‘Minor loss of function’ includes cases with no comorbidity or complication.
11.33% of observations missing data on this variable.